CIK 0000818033
- Accelerated filer
HERON THERAPEUTICS, INC. /DE/
Sign in to watch- Ticker
- HRTX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 942875566
- Phone
- +1 858-251-4400
- Business address
- 4242 CAMPUS POINT COURT, SUITE 200, SAN DIEGO, CA, 92121
- Former names
- AP PHARMA INC /DE/, ADVANCED POLYMER SYSTEMS INC /DE/
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2016-04-21 | Rosen Robert President | Exercise or conversion · Employee Stock Option (Right to Buy) | −19,662 | 925,000 | ||
| 2016-04-20 | Rosen Robert President | Exercise or conversion | +4,010 | $7.20 | $29K | 6,650 |
| 2016-04-20 | Rosen Robert President | Sale | −4,010 | $22.19 | $89K | 2,640 |
| 2016-04-20 | Rosen Robert President | Exercise or conversion · Employee Stock Option (Right to Buy) | −4,010 | 944,662 | ||
| 2016-04-19 | Rosen Robert President | Exercise or conversion | +176,328 | $7.20 | $1.3M | 178,968 |
| 2016-04-19 | Rosen Robert President | Sale | −60,925 | $22.50 | $1.4M | 118,043 |
| 2016-04-19 | Rosen Robert President | Sale | −76,949 | $23.47 | $1.8M | 41,094 |
| 2016-04-19 | Rosen Robert President | Sale | −32,224 | $24.49 | $789K | 8,870 |
| 2016-04-19 | Rosen Robert President | Sale | −6,230 | $25.11 | $156K | 2,640 |
| 2016-04-19 | Rosen Robert President | Exercise or conversion · Employee Stock Option (Right to Buy) | −176,328 | 948,672 | ||
| 2016-03-21 | Marshall Paul SVP, Technical Operations | Exercise or conversion | +1,100 | $9.05 | $10K | 2,200 |
| 2016-03-21 | Marshall Paul SVP, Technical Operations | Exercise or conversion · Employee Stock Option (Right to Buy) | −1,100 | 42,800 | ||
| 2016-03-02 | Quart Barry D Chief Executive Officer | Exercise or conversion | +3,472 | $7.20 | $25K | 60,842 |
| 2016-03-02 | Quart Barry D Chief Executive Officer | Exercise or conversion · Employee Stock Option (Right to Buy) | −3,472 | 934,907 | ||
| 2016-01-28 | MANHARD KIMBERLY Executive VP, Drug Development | Grant or award · Employee Stock Option (Right to Buy) | +300,000 | 300,000 | ||
| 2015-12-29 | Marshall Paul SVP, Technical Operations | Exercise or conversion | +1,100 | $9.05 | $10K | 1,100 |
| 2015-12-29 | Marshall Paul SVP, Technical Operations | Exercise or conversion · Stock Option (Right to Buy) | −1,100 | 43,900 | ||
| 2015-12-28 | Quart Barry D Chief Executive Officer | Exercise or conversion | +2,315 | $7.20 | $17K | 82,370 |
| 2015-12-28 | Quart Barry D Chief Executive Officer | Exercise or conversion · Stock Option (Right to Buy) | −2,315 | 938,379 | ||
| 2015-12-22 | TANG KEVIN C Director | Grant or award · Stock Option (right to buy) | +17,000 | 17,000 |
Page 36 of 38 · 746 trades